All Videos

Julie Harper, MD, talks about the Epsolay drug approval that happened April 25. She dives into its mechanism of action, its potential as both a first line treatment or combination therapy, and what she would like to see next in its research.

Ilanit Samuels, PA-C, talks the future of aesthetics and the trends she sees while treating her patients at the Florida Society of Dermatology Physician Assistants 2022 New Wave Dermatology Conference.

Scott Freeman, PA-C, talks post-procedure infection prevention at the current New Wave Dermatology conference.

IIanit Samuels, PA-C, of Illy Aesthetics, discusses the importance of thorough injectable training.

Scott Freeman, PA-C, discusses the future role of physician assistants in dermatology practice.

Tanya Patron, PA-C, the owner and founder of the Selfie Aesthetic, gave an important talk on neurotoxins at the 2022 New Wave Dermatology Conference in Coral Gables, Florida.

Scott Freeman, PA-C, gives an overview of the hands-on surgery workshop at the current New Wave Dermatology Conference.

Heather Gates, PA-C, the vice president of the Florida Society of Dermatology Physician Assistants gives highlights of what is to come this weekend at the 2022 New Wave Dermatology Conference.

In this week’s Pointers with Dr Portela, the 208SkinDoc shows a talk he gave to students interested in a possible career in medicine.

In this interview, Andrew Blauvelt, MD, MBA, explains how nurse practitioners (NPs) can better counsel psoriasis patients and why its important that NPs have the top knowledge on current dermatologic treatments.

In this video interview, Andrew Blauvelt, MD, MBA, dives into the current state of atopic dermatitis treatment from his talk presented at the Annual Society of Dermatology Nurse Practitioners Symposium, held April 22-23, in Nashville, Tennessee.

In this video interview, Andrew Blauvelt, MD, MBA, dermatologist and clinical researcher at the Oregon Medical Research Center, highlights his key takeaways from his presentation at the Annual Society of Dermatology Nurse Practitioners Symposium, held April 22-23, in Nashville, Tennessee.

In this week’s Pointers with Dr Portela, the 208SkinDoc lists the top 5 ingredients to look for when patients are choosing over the counter solutions.

In this video interview, Darren Smith, MD, comments on the Renuvion/J-Plasma device (Apyx Medical) receiving an FDA warning for dermal resurfacing or skin contraction. He dives into how the device may be causing these issues, how this affects patients, and more.

Andrew Blauvelt, MD, MBA, shares clinical pearls for the management of atopic dermatitis with systemic therapy.

An expert dermatologist provides insight on unmet needs in clinical trial endpoint measurements that would improve the management of atopic dermatitis.

Dr Andrew Blauvelt discusses the relevance of dupilumab treatment response as seen in the LIBERTY AD OLE and LIBERTY AD CHRONOS studies and shares his approaches to improving atopic dermatitis management.

In this week’s Pointers with Dr Portela, the 208SkinDoc highlights alopecia, discussing the different types, and the emotional impact of hair loss.

Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, talks about how education of patients is so important, the upcoming parts of the AAD guidelines to look forward to, and more.

Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research expands on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is held from April 9 to 11 in Baltimore, Maryland.

Lawrence Eichenfield, MD, of Rady Children's Hospital-San Diego, discusses the American Academy of Dermatology's approach to atopic dermatitis management.

Lawrence Eichenfield, MD, of Rady Children's Hospital-San Diego, California, discusses the importance of recognizing children with more severe atopic disease and a team approach to treatment.

Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research, explores the hidden burdens of itch that many pediatric patients and parents have to deal with on a daily basis. She expanded on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference was held from April 9 to 11 in Baltimore, Maryland

What do topical PDE4 inhibitors bring to the treatment toolbox? Which patients are likely to get the most use out of them? Robert Sidbury, MD, MPH, answers these questions and more in this video interview.

Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research dives into the importance of the results from their recently released study.

Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, expands on his AD overview from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is being held from April 9 to 11 in Baltimore, Maryland.

Andrew Blauvelt, MD, MBA, reviews clinical implications from the phase 3 LIBERTY AD CHRONOS study examining the efficacy of dupilumab plus topical corticosteroids in adult patients with moderate to severe atopic dermatitis.

An expert dermatologist provides key takeaways and the real-world significance of dupilumab use for the treatment of atopic dermatitis.

Terri Phillips, MD, FAAP, expands on her letter to the editor in the April issue of Dermatology Times® diving into how her experience has shaped the her view of the aesthetics industry, the challenges both physicians and patients face, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc attended the 2022 American Academy of Dermatology (AAD) Annual Meeting and talked to several dermatologists about skin care and common misconceptions about this topic.